Dachaigh › Aillse nan dubhagan › Massachusetts › Boston
Sgrùdaidhean clionaigeach Aillse nan dubhagan ann an Boston, MA
Tha 12 sgrùdaidhean airson Aillse nan dubhagan a’ lorg phàirtichean aig làraichean ann agus timcheall air Boston (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
A’ fastadhÌre 1
- Research Site, Boston
Distance-Based Exercise to Preserve Function and Prevent Disability
A’ fastadh
- Dana-Farber Cancer Institute, Boston
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
A’ fastadhÌre 3
- Research Site, Boston
- Research Site, Boston
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
A’ fastadhÌre 1/2
- Brigham and Women's Hospital, Boston
- Dana Farber/Mass General Brigham Cancer Care, Inc, Boston
A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
A’ fastadhÌre 2
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
A’ fastadhÌre 1
- Dana-Farber Cancer Institute, Boston
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
A’ fastadhÌre 1
- Dana-Farber Cancer Institute, Boston
Video Education With Result Dependent dIsclosure
A’ fastadh
- Dana Farber Cancer Institute, Boston
Drug Screening Using Novel IMD in Renal Cell Carcinoma
A’ fastadhÌre 1
- Dana-Farber Cancer Institute, Boston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
A’ fastadhÌre 1/2
- Massachusetts General Hospital, Boston
Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC
A’ fastadhÌre 2
- Beth Israel Deaconess Medical Center, Boston
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Stereotactic Magnetic Resonance Guided Radiation Therapy
A’ fastadh
- Brigham & Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Sgrùdaidhean Aillse nan dubhagan ann am bailtean eile
- New York City, NY15 sgrùdaidhean
- Nashville, TN12 sgrùdaidhean
- Houston, TX10 sgrùdaidhean
- San Diego, CA9 sgrùdaidhean
- St. Louis, MO9 sgrùdaidhean
- Dallas, TX9 sgrùdaidhean
- Washington, DC9 sgrùdaidhean
- Seattle, WA8 sgrùdaidhean
- Edison, NJ8 sgrùdaidhean
- Miami, FL8 sgrùdaidhean
- Los Angeles, CA7 sgrùdaidhean
- Rochester, MN7 sgrùdaidhean
Sgrùdaidhean eile ann an Boston
- Aillse a' bhroilleach112 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag90 sgrùdaidhean
- Aillse (gach seòrsa)85 sgrùdaidhean
- Ailse metastatach63 sgrùdaidhean
- Aillse colorectal63 sgrùdaidhean
- Ailseachadh nan Sgamhan62 sgrùdaidhean
- Cancer Ovarian61 sgrùdaidhean
- Aillse Prostata59 sgrùdaidhean
- Depression52 sgrùdaidhean
- Ailse Endometrial50 sgrùdaidhean
- Fàilligeadh a' Chridhe44 sgrùdaidhean
- Leukemia myeloid geur44 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.